Marcela Amitrano Bilobran
Research Subjects
Marcela Amitrano Bilobran has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrezza Helena Regadas Muniz
Instituto Nacional de Câncer (INCA), Hospital do Câncer IV (HCIV), Unidade de Cuidados Paliativos. Rio de Janeiro (RJ), Brasil
2 shared publications - Livia Costa de Oliveira
GPQual—Palliative Care and Quality of Life Research Group, Barretos Cancer Hospital, São Paulo, Brazil
2 shared publications - Maria Fernanda Fernandes Duarte Costa
Hospital Escola Álvaro Alvim, Oncocentro - Campos dos Goytacazes, Rio de Janeiro, Brazil
2 shared publications - Patricia Almeida Chelles
Instituto Nacional de Câncer, Hospital do Câncer IV, Divisão Técnico Assistencial - Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications - Simone Garruth dos Santos Machado Sampaio
Doutora. Médica. Unidade de Cuidados Paliativos do Hospital do Câncer IV (HC IV) do Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil
2 shared publications - Edson Tavares da Silva Neto
Casa de Saúde São José, Centro de Tratamento Intensivo - Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication
Latest Publications
- Open Access
- 9 September 2024
- Published by Academia Nacional de Cuidados Paliativos in Latin American Journal of Palliative Care
- Vol. 3
Assessment of pain control in advanced cancer patients admitted to a palliative care unit
Introduction: Pain in people with cancer is prevalent and should have an individualized therapeutic plan. Objectives: To evaluate pain control in advanced cancer patients in a hospital palliative care unit. Methods: This is a cohort study, with prospective design, and quantitative approach, including advanced cancer patients admitted to a palliative care unit between June 2021 and February 2022 reporting pain. Data was collected from medical records and the Brief Pain Inventory (BPI) was used to assess pain on the first (D1), third (D3) and seventh (D7) day of hospitalization. Results: One hundred and four patients participated in the study. The most prevalent tumors were of the gastrointestinal tract (n=23; 22%), cervix (n=21; 20%) and breast (n=17; 16%). Abdomen was the most reported site of pain (n=34; 33%), with 50% classified as nociceptive pain, 39% neuropathic pain, and 11% mixed. On D1, 43% reported severe pain, 31% moderate, and 12% mild pain. There was an evolutionary drop in the percentage of severe pain (BPI3 70% to 37.1%; BPI4 12.6% to 5.4%; BPI5 42.5% to 13.5%; and BPI9 67.8% to 21.6%) according to the answers to all BPI questions during the period. On D1, D3 and D7, the average equipotent doses of oral morphine were 116 mg, 133 mg and 154 mg and the frequency of use of adjuvant use was 60%, 75%, and 69%, respectively. Conclusions: Pain was properly controlled and was related to the increased use of adjuvants, both for general and neuropathic pain. It was possible to observe that the use of adjuvants was related to better pain control.
- 9 September 2024
- Published by Academia Nacional de Cuidados Paliativos in Latin American Journal of Palliative Care
- Vol. 3
Open AccessAssessment of pain control in advanced cancer patients admitted to a palliative care unit
Introduction: Pain in people with cancer is prevalent and should have an individualized therapeutic plan. Objectives: To evaluate pain control in advanced cancer patients in a hospital palliative care unit. Methods: This is a cohort study, with prospective design, and quantitative approach, including advanced cancer patients admitted to a palliative care unit between June 2021 and February 2022 reporting pain. Data was collected from medical records and the Brief Pain Inventory (BPI) was used to assess pain on the first (D1), third (D3) and seventh (D7) day of hospitalization. Results: One hundred and four patients participated in the study. The most prevalent tumors were of the gastrointestinal tract (n=23; 22%), cervix (n=21; 20%) and breast (n=17; 16%). Abdomen was the most reported site of pain (n=34; 33%), with 50% classified as nociceptive pain, 39% neuropathic pain, and 11% mixed. On D1, 43% reported severe pain, 31% moderate, and 12% mild pain. There was an evolutionary drop in the percentage of severe pain (BPI3 70% to 37.1%; BPI4 12.6% to 5.4%; BPI5 42.5% to 13.5%; and BPI9 67.8% to 21.6%) according to the answers to all BPI questions during the period. On D1, D3 and D7, the average equipotent doses of oral morphine were 116 mg, 133 mg and 154 mg and the frequency of use of adjuvant use was 60%, 75%, and 69%, respectively. Conclusions: Pain was properly controlled and was related to the increased use of adjuvants, both for general and neuropathic pain. It was possible to observe that the use of adjuvants was related to better pain control.
- 27 March 2024
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 14 (e2) , e2079-e2086
Pain management effectiveness in advanced cancer: palliative care unit inpatient study
Objectives The aim of this study is to evaluate pain management adequacy based on the Pain Management Index (PMI), and its association with the Brief Pain Inventory (BPI) in advanced cancer inpatients to a palliative care unit. Methods This is a quantitative study concerning advanced cancer inpatients in a specialised palliative care unit between June 2021 and February 2022. The BPI was applied, and analgesia was observed on the first (D1), third (D3) and seventh (D7) day of hospitalisation. Adequate analgesia was considered when PMI≥0. Results A total of 104 patients were evaluated on D1, 68 on D3 and 45 on D7, with a mean age of 53.6 years (SD±14.1), most of them female (65.4%), with the most frequent primary tumour site located in the gastrointestinal tract (22.1%). The observed analgesia was adequate (PMI≥0) in 52.9% of all patients on D1, 95.6% on D3 and 100% on D7 (p value=0.012). The number of patients with moderate to severe pain interference in general activities (p value 0.012), mood (p value 0.014), walking ability (p value 0.047), normal work (p value 0.038) and pleasure of living (p value 0.025) decreased during hospitalisation. Conclusions Pain is a prevalent and impacting symptom in patients undergoing palliative care. Thus, objective analgesic adequacy assessments in specialised services are required. These findings reinforce the importance of effective pain control and corroborate the importance of employing objective tools in evaluating medical services and improving quality of life of patients.
- 27 March 2024
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 14 (e2) , e2079-e2086
Pain management effectiveness in advanced cancer: palliative care unit inpatient study
Objectives The aim of this study is to evaluate pain management adequacy based on the Pain Management Index (PMI), and its association with the Brief Pain Inventory (BPI) in advanced cancer inpatients to a palliative care unit. Methods This is a quantitative study concerning advanced cancer inpatients in a specialised palliative care unit between June 2021 and February 2022. The BPI was applied, and analgesia was observed on the first (D1), third (D3) and seventh (D7) day of hospitalisation. Adequate analgesia was considered when PMI≥0. Results A total of 104 patients were evaluated on D1, 68 on D3 and 45 on D7, with a mean age of 53.6 years (SD±14.1), most of them female (65.4%), with the most frequent primary tumour site located in the gastrointestinal tract (22.1%). The observed analgesia was adequate (PMI≥0) in 52.9% of all patients on D1, 95.6% on D3 and 100% on D7 (p value=0.012). The number of patients with moderate to severe pain interference in general activities (p value 0.012), mood (p value 0.014), walking ability (p value 0.047), normal work (p value 0.038) and pleasure of living (p value 0.025) decreased during hospitalisation. Conclusions Pain is a prevalent and impacting symptom in patients undergoing palliative care. Thus, objective analgesic adequacy assessments in specialised services are required. These findings reinforce the importance of effective pain control and corroborate the importance of employing objective tools in evaluating medical services and improving quality of life of patients.